Jenny Liu
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 2
- Since medical school
- 6 years
- Graduated 2020
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Jenny Liu’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
State licence records
1 licence
- Illinois 125075807Temporary Medical Permit · since 2020 · expires 2023-06-30Specialty on the licence: Internal MedicineExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$2,628
Medicare paid this office $2,628 for 62 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| X-ray of knee, 3 views | 12 | $214 | $14 |
| X-ray of chest, 2 views | 11 | $182 | $17 |
Who their Medicare patients are
62 Original Medicare patients in 2024. Average age 74 · Women 76% · Health risk score 1.30. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 65% · Diabetes 48%.
The office billed $43,503, Medicare allowed $4,307 and paid $2,628; for 90 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 62 | 90 | 74 | 1.30 | $43,503 | $2,628 |
| 2023 | 11 | 13 | 73 | 1.10 | $6,607 | $404 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$728,178 in 2024
Medicaid paid $728,178 for 15,725 billed services this clinician did in 2024, up to 153 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,264 | $636,328 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 197 | $88,310 |
| Short return visit (20+ min) | 2,143 | $2,535 |
| New patient visit (30+ min) | 53 | $314 |
| Blood test, lipids (cholesterol and triglycerides) | 125 | $252 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 12 | $128 |
| Thyroid stimulating hormone (TSH) | 72 | $92 |
| Hemoglobin A1C level | 217 | $87 |
| Return visit (30+ min) | 539 | $69 |
| ELECTROLYTE PANEL | 127 | $23 |
| Creatinine; blood | 131 | $16 |
| Blood glucose (sugar) level | 127 | $12 |
| 2024 | 15,725 | 33 | 153 | $728,178 |
| 2023 | 1,649 | 20 | 95 | $126,639 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 234 | $117,426 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 20 | $8,936 |
| Short return visit (20+ min) | 279 | $244 |
| Hemoglobin A1C level | 32 | $17 |
| Thyroid stimulating hormone (TSH) | 13 | $15 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 91 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 183 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 69 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 89 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 229 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 72 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 42 | $0 |
Drugs they prescribed that Part D paid
$343,621
Pharmacies billed $343,621 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (107 of 3,314) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
2,848 generic and 445 brand-name prescriptions · $343,621 in drug cost · 39 antibiotic prescriptions to 27 people · 19 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 36 | $46,542 | $1,293 |
| Ozempic | 38 | $38,120 | $1,003 |
| Eliquis | 27 | $33,444 | $1,239 |
| Trulicity | 25 | $29,856 | $1,194 |
| Rybelsus | 20 | $21,358 | $1,068 |
See all 78 drugs
| Jardiance | 36 | $46,542 | $1,293 |
| Ozempic | 38 | $38,120 | $1,003 |
| Eliquis | 27 | $33,444 | $1,239 |
| Trulicity | 25 | $29,856 | $1,194 |
| Rybelsus | 20 | $21,358 | $1,068 |
| Tradjenta | 14 | $18,490 | $1,321 |
| Vemlidy | 12 | $16,515 | $1,376 |
| Myrbetriq | 14 | $13,184 | $942 |
| Januvia | 16 | $11,381 | $711 |
| Incruse Ellipta | 16 | $5,690 | $356 |
| Basaglar Kwikpen U-100 | 21 | $4,381 | $209 |
| Semglee (Yfgn) | 11 | $4,139 | $376 |
| Diclofenac | 70 | $2,129 | $30 |
| Albuterol Sulfate Hfa | 50 | $2,094 | $42 |
| Atorvastatin | 216 | $1,208 | $6 |
| Gabapentin | 81 | $1,201 | $15 |
| Ultra-Fine Mini Pen Needle | 15 | $1,168 | $78 |
| Mirtazapine | 27 | $1,089 | $40 |
| Losartan | 133 | $1,070 | $8 |
| Insulin Aspart Flexpen | 15 | $924 | $62 |
| Isosorbide Dinitrate | 14 | $902 | $64 |
| Lantus Solostar | 13 | $865 | $67 |
| Lidocaine | 16 | $852 | $53 |
| Tamsulosin | 50 | $788 | $16 |
| Rosuvastatin | 29 | $715 | $25 |
| Omeprazole | 91 | $666 | $7 |
| Levothyroxine | 74 | $664 | $9 |
| Metoprolol | 37 | $635 | $17 |
| Oxycodone-Acetaminophen | 27 | $622 | $23 |
| Metformin | 106 | $546 | $5 |
| Amlodipine Besylate | 149 | $508 | $3 |
| Clotrimazole | 32 | $501 | $16 |
| Fosinopril | 22 | $464 | $21 |
| Fluticasone Propionate | 57 | $460 | $8 |
| Baclofen | 36 | $427 | $12 |
| Triamcinolone Acetonide | 50 | $410 | $8 |
| Amlodipine Besylate-Benazepril | 22 | $394 | $18 |
| Levetiracetam | 11 | $380 | $35 |
| Valsartan | 15 | $376 | $25 |
| Famotidine | 36 | $367 | $10 |
| Alendronate | 61 | $348 | $6 |
| Losartan-Hydrochlorothiazide | 15 | $302 | $20 |
| Pantoprazole | 37 | $289 | $8 |
| Finasteride | 21 | $276 | $13 |
| Hydrocortisone | 33 | $260 | $8 |
| Hydrocodone-Acetaminophen | 26 | $230 | $9 |
| Ibuprofen | 38 | $229 | $6 |
| Pregabalin | 11 | $227 | $21 |
| Glipizide | 28 | $218 | $8 |
| Fluocinonide | 11 | $212 | $19 |
| Bupropion Xl | 13 | $208 | $16 |
| Meclizine | 21 | $204 | $10 |
| Ketoconazole | 13 | $202 | $16 |
| Tramadol | 44 | $195 | $4 |
| Hydralazine | 25 | $190 | $8 |
| Trazodone | 29 | $186 | $6 |
| Celecoxib | 12 | $183 | $15 |
| Tizanidine | 25 | $179 | $7 |
| Sertraline | 24 | $161 | $7 |
| Furosemide | 33 | $155 | $5 |
| Clopidogrel | 16 | $150 | $9 |
| Ondansetron Odt | 16 | $150 | $9 |
| Hydrochlorothiazide | 65 | $148 | $2 |
| Mupirocin | 24 | $145 | $6 |
| Naproxen | 19 | $139 | $7 |
| Duloxetine | 11 | $137 | $12 |
| Pravastatin | 17 | $133 | $8 |
| Simvastatin | 34 | $126 | $4 |
| Lisinopril | 39 | $114 | $3 |
| Fluoxetine | 13 | $110 | $8 |
| Montelukast | 14 | $104 | $7 |
| Allopurinol | 19 | $103 | $5 |
| Metoprolol | 42 | $100 | $2 |
| Cyclobenzaprine | 15 | $96 | $6 |
| Carvedilol | 12 | $95 | $8 |
| Clonazepam | 22 | $93 | $4 |
| Amitriptyline | 11 | $64 | $6 |
| Metformin Hcl Er | 12 | $46 | $4 |
Year by year
| 2024 | 3,314 | 310 | 3% (107) | 13% | $343,621 |
| 2023 | 318 | 121 | 5% (15) | None | $39,554 |
| 2021 | 70 | None | 0% (0) | None | $3,971 |
| 2020 | 57 | 16 | None | None | $1,632 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Losartan | 11 | $433 | $39 |
| Atorvastatin | 15 | $300 | $20 |
| Amlodipine Besylate | 15 | $217 | $14 |
Money from drug and device companies
$18 in 2025
| 2025 | 1 | 1 | None | $18 |
| 2024 | 1 | 1 | None | $15 |
| 2020 | 1 | 1 | None | $9 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $18 | 1 payment
|
See the published payment
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-22 | Airsupra | $18 |
See earlier years (2024, 2020)
2024: $15
| AstraZeneca Pharmaceuticals LP | Airsupra | $15 | 1 payment
|
2020: $9
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $9 | 1 payment
|
Professional record
- NPI
- 1003444290
- Licence
- IL 125.075807Illinois 125075807: Expired
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S. Bascom Ave., San Jose, CA, 95128
- NPI first listed
- 2020-04-01
- NPI last updated
- 2023-07-10
- NPI record certified
- 2023-07-10
This is when the NPI record was last certified, not a medical board exam.